Expression of functional CB1cannabinoid receptors in retinoic acid‐differentiated P19 embryonal carcinoma cells
- 13 February 2006
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 83 (6) , 1128-1140
Abstract
Although primary neuronal cell cultures, usually obtained from embryonic or early postnatal rodents, have been used in vitro to study the neural cannabinoid signalling system, development of cell lines with neural properties exhibiting native expression of cannabinoid receptors is desirable. This study was undertaken to investigate the expression of CB1and CB2cannabinoid receptors in neurons that develop from retinoic acid (RA)‐primed mouse P19 embryonal carcinoma cells. Both undifferentiated P19 cells and RA‐treated P19 neurons were positive, by using reverse transcription‐polymerase chain reaction (RT‐PCR), for CB1(but not CB2) mRNA. Neuronal differentiation increased the CB1mRNA expression, and Western blotting with a CB1receptor antibody showed a strong immunoreactive band at approximately 62 kDa in membranes from P19‐derived neurons. The cannabinoid receptor agonists CP 55,940 and HU‐210 produced concentration‐dependent inhibition of forskolin‐induced (3 μM) cyclic AMP production in the P19‐derived neurons (29% at 1 μM CP 55,940 and 34% at 1 μM HU‐210), which could be blocked by the CB1‐selective receptor antagonist AM251, but not by the CB2‐selective antagonist AM630. Furthermore, glutamate (100 μM) induced a sustained increase in [Ca2+]iin P19‐derived neurons that could be concentration‐dependently blocked by the cannabinoid receptor agonists WIN 55,212‐2. Thus, the protocol used provides an in vitro model system expressing CB1cannabinoid receptors at the level of mRNA, protein, and AM251‐sensitive agonist‐induced inhibition of intracellular cyclic AMP accumulation, which may be useful to investigate the developmental regulation, expression and function of neuronal cannabinoid receptors.Keywords
This publication has 74 references indexed in Scilit:
- Cannabinoid signallingLife Sciences, 2006
- Identification and Functional Characterization of Brainstem Cannabinoid CB2ReceptorsScience, 2005
- A Predominant Role for Inhibition of the Adenylate Cyclase/Protein Kinase A Pathway in ERK Activation by Cannabinoid Receptor 1 in N1E-115 Neuroblastoma CellsJournal of Biological Chemistry, 2003
- Pharmacological Properties of Cannabinoid Receptors in the Avian Brain: Similarity of Rat and Chicken Cannabinoid1 Receptor Recognition Sites and Expression of Cannabinoid2 Receptor-Like Immunoreactivity in the Embryonic Chick BrainBasic & Clinical Pharmacology & Toxicology, 2001
- Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptorsLife Sciences, 1997
- Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cell linesJournal of Neuroscience Research, 1996
- Glutamate receptor-mediated calcium entry in neurons derived from P19 embryonal carcinoma cellsJournal of Neuroscience Research, 1996
- Neurons derived from P19 embryonal carcinoma cells develop responses to excitatory and inhibitory neurotransmittersDevelopmental Brain Research, 1995
- Glutamate Receptor‐Mediated Calcium Surges in Neurons Derived from P19 CellsJournal of Neurochemistry, 1995
- Expression of Ionotropic Glutamate Receptor Genes by P19 Embryonal Carcinoma CellsBiochemical and Biophysical Research Communications, 1993